Chris Oomen
SwitzerlandinvestorMale6.0Global Dominance: 0.00%Chris Oomen is a significant shareholder in Kuros Biosciences, holding nearly a quarter of the company's stock through his investment company Optiver. His involvement is crucial as Kuros navigates its growth trajectory and potential acquisition interests from larger firms like Medtronic.
Power618
Reach7,645
Country presence
Recent news mentions
Chris Oomen is a major shareholder in Kuros, holding nearly a quarter of the shares through Optiver.
Kuros Biosciences bieten einen riskanten, aber attraktiven Investment CaseNeue Zürcher Zeitung·Switzerland· 2026-07-23
Switzerland· 2026-07-23
